Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefits of Early Initiation of Continuous Renal Replacement Therapy (CRRT) in Patients With Severe Sepsis

NCT03141112 is registered in ClinicalTrials.gov with Radovan Uvizl as lead sponsor.

NCT NCT03141112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03141112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefits of Early Initiation of Continuous Renal Replacement Therapy (CRRT) in Patients With Severe Sepsis
Lead sponsor
Radovan Uvizl
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2016
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis